CD4 and neoplasm: CDK4/6 inhibition suppresses CD4+ Tregs more than CD8+ cytotoxic T cells, increases the CD8+ T cells/Tregs ratio in the tumor microenvironment, and, when combined with an ICI, leads to the clearance of tumor cells by cytotoxic T cells [96].